Propanc Biopharma
PPCB
#11204
Rank
C$2.67 M
Marketcap
C$2.55
Share price
3.19%
Change (1 day)
123.48%
Change (1 year)

Earnings for Propanc Biopharma (PPCB)

Earnings in 2026 (TTM): -C$26.31 Million

According to Propanc Biopharma's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$2.4 Million, an increase over its 2023 earnings that were of -C$3.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Propanc Biopharma from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$26.31 Million
2024 -C$2.4 Million-36.3%
2023 -C$3.77 Million0.89%
2022 -C$3.73 Million-2.16%
2021 -C$3.81 Million18.75%
2020 -C$3.21 Million-60.41%
2019 -C$8.11 Million-14.46%
2018 -C$9.48 Million-13.29%
2017 -C$10.93 Million-22.86%
2016 -C$14.16 Million46.22%
2015 -C$9.69 Million351.36%
2014 -C$2.15 Million29.49%
2013 -C$1.66 Million-82.48%
2012 -C$9.46 Million-7.39%
2011 -C$10.22 Million